David Sinclair, Ph.D. is a co-founder of Sirtris Pharmaceuticals and Associate Professor of Pathology at Harvard Medical School. He has made key contributions to the scientific understanding of aging. In 1997, David identified the cause of aging in yeast, a first for any species, and in 2003 reported the discovery of a conserved master regulatory gene controlling this process. David has authored more than 20 peer-reviewed scientific publications, including several seminal papers in Nature and Science, and has received numerous awards and honors for his research.
David Sinclair performed his post-doctoral work with Dr. Leonard Guarente at MIT and holds a PhD in Biochemistry and Molecular Genetics from the University of New South Wales.
And actually a PhD and business mind I'm told is a rare breed. And often as being an academic assume is a negative. And they just want you to get the heck out of the way and let business people do their job. And so I have actually spent a lot of time at the company doing business. Learning on t...(Full transcript available to logged in subscribers.).
Register & Subscribe
Login
David Sinclair Shares Thoughts on Time Requirements of Being a Scientist and Entrepreneur
David Gottlieb Discusses Importance of Reducing Risk In Transitioning Technology To A Commercial Enterprise
David Gottlieb States Initial Public Offering May Not Be Too Far Off As A Financing Option
